Year |
Citation |
Score |
2021 |
Ojha R, Chen IC, Hsieh CM, Nepali K, Lai RW, Hsu KC, Lin TE, Pan SL, Chen MC, Liou JP. Installation of Pargyline, a LSD1 Inhibitor, in the HDAC Inhibitory Template Culminated in the Identification of a Tractable Antiprostate Cancer Agent. Journal of Medicinal Chemistry. PMID 34908406 DOI: 10.1021/acs.jmedchem.1c00966 |
0.664 |
|
2020 |
Ojha R, Nepali K, Chen CH, Chuang KH, Wu TY, Lin TE, Hsu KC, Chao MW, Lai MJ, Lin MH, Huang HL, Chang CD, Pan SL, Chen MC, Liou JP. Corrigendum to"Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo"[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086]. European Journal of Medicinal Chemistry. 201: 112404. PMID 32526554 DOI: 10.1016/J.Ejmech.2020.112404 |
0.67 |
|
2020 |
Ojha R, Nepali K, Chen CH, Chuang KH, Wu TY, Lin TE, Hsu KC, Chao MW, Lai MJ, Lin MH, Huang HL, Chang CD, Pan SL, Chen MC, Liou JP. Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo. European Journal of Medicinal Chemistry. 190: 112086. PMID 32058238 DOI: 10.1016/J.Ejmech.2020.112086 |
0.719 |
|
2019 |
Thakur A, Singh A, Kaur N, Ojha R, Nepali K. Steering the antitumor drug discovery campaign towards structurally diverse indolines. Bioorganic Chemistry. 103436. PMID 31761410 DOI: 10.1016/J.Bioorg.2019.103436 |
0.426 |
|
2018 |
Lai MJ, Ojha R, Lin MH, Liu YM, Lee HY, Lin TE, Hsu KC, Chang CY, Chen MC, Nepali K, Chang JY, Liou JP. 1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase. European Journal of Medicinal Chemistry. 162: 612-630. PMID 30476825 DOI: 10.1016/J.Ejmech.2018.10.066 |
0.688 |
|
2018 |
Ojha R, Huang HL, HuangFu WC, Wu YW, Nepali K, Lai MJ, Su CJ, Sung TY, Chen YL, Pan SL, Liou JP. 1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC. European Journal of Medicinal Chemistry. 150: 667-677. PMID 29567459 DOI: 10.1016/J.Ejmech.2018.03.006 |
0.716 |
|
2016 |
Nepali K, Lee HY, Lai MJ, Ojha R, Wu TY, Wu GX, Chen MC, Liou JP. Ring-opened tetrahydro-γ-carbolines display cytotoxicity and selectivity with histone deacetylase isoforms. European Journal of Medicinal Chemistry. 127: 115-127. PMID 28038324 DOI: 10.1016/J.Ejmech.2016.12.039 |
0.681 |
|
2016 |
Ojha R, Singh J, Ojha A, Singh H, Sharma S, Nepali K. An updated patent review: Xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015). Expert Opinion On Therapeutic Patents. PMID 27841045 DOI: 10.1080/13543776.2017.1261111 |
0.373 |
|
2016 |
Nepali K, Ojha R, Lee HY, Liou JP. Early investigational tubulin inhibitors as novel cancer therapeutics. Expert Opinion On Investigational Drugs. PMID 27186892 DOI: 10.1080/13543784.2016.1189901 |
0.582 |
|
2014 |
Singh H, Sharma S, Ojha R, Gupta MK, Nepali K, Bedi PM. Synthesis and evaluation of naphthoflavones as a new class of non purine xanthine oxidase inhibitors. Bioorganic & Medicinal Chemistry Letters. 24: 4192-7. PMID 25106887 DOI: 10.1016/j.bmcl.2014.07.041 |
0.418 |
|
2014 |
Shukla S, Kumar D, Ojha R, Gupta MK, Nepali K, Bedi PM. 4,6-Diaryl/heteroarylpyrimidin-2(1H)-ones as a new class of xanthine oxidase inhibitors. Archiv Der Pharmazie. 347: 486-95. PMID 24782427 DOI: 10.1002/ardp.201400031 |
0.45 |
|
Show low-probability matches. |